Use official prescribing information and clinician advice for any semaglutide product.
Open related pageCalculator safety
semaglutide calculator
This page does not calculate semaglutide doses, compound dosing, CagriSema combinations, or retatrutide conversions.
Direct answer
Semaglutide products have FDA-approved prescription labels for specific uses, but dosing, titration, missed doses, and switching decisions belong with a licensed clinician.
Retatrutide is investigational and should not be converted from semaglutide.
Open related pageCagriSema is a separate investigational combination product, not a DIY add-on.
Open related pageWhat to know before acting on this search
- Semaglutide is a GLP-1 receptor agonist with FDA-approved prescription products for specific labeled uses.
- Compounded products are not FDA approved, and FDA has raised concerns about compounded GLP-1 drugs.
- CagriSema's semaglutide component does not make CagriSema approved before regulatory approval.
- Dose and safety questions should be handled by the prescribing clinician.
Safety and compliance notes
- Do not use semaglutide calculators to self-adjust a prescription or compounded product.
- Do not combine semaglutide with research-use retatrutide, cagrilintide, or CagriSema-like products.
- Severe nausea, vomiting, dehydration, abdominal pain, fainting, allergic symptoms, or other concerning symptoms warrant medical care.
Safer next step
Read official label context and ask a qualified healthcare provider about approved options, side effects, and monitoring.
Medical disclaimer
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. I am not a medical professional. Always consult a qualified healthcare provider before starting, stopping, or changing any weight loss treatment. Individual results vary. FDA-approved medicines such as semaglutide and tirzepatide require prescriptions and should only be used under medical supervision.